• Emphasizing on self-care, Maxwellia is planning to launch three pharmacy products.
  • Maxwellia wants to convert more prescription medicines to over-the-counter medicines.
  • This move can expand the role of pharmacists at public health.

Planning to give people easier and faster access to the necessary treatments by converting prescription-only medicines to versions that can be bought at a pharmacy counter, pioneering pharma company Maxwellia is likely to transform the self-care market in the United Kingdom (UK).

Maxwellia is preparing the list of medicines which can treat a range of conditions in major public health categories whose purchase can be allowed without any prescription. Medicines and Healthcare products Regulatory Agency (MHRA) is assessing the three applications of Maxwellia which include women’s health products. Widening access to many medicines can not only help people to manage and control their own health, it can also broaden the role of pharmacists.

MHRA has a rigorous process to allow the purchase of a medicine without prescription. In past, the purchase of Canesten, Nurofen, and Viagra Connect has been allowed without prescription. During the COVID-19 pandemic, pharmacies have been very instrumental in helping people regarding self-care. According to a research conducted during last year’s first national lockdown, from the Photographic Alliance of Great Britain (PAGB), the consumer healthcare association, 69% of respondents were more likely to consider self-care as their first option.

Anna Maxwell, Maxwellia CEO, says that the pandemic showed people that it was necessary to take care of health. With so many people needing doctors, it was difficult to get appointments with many general practitioners (GPs) who were over-stretched. Allowing the sales of more medicines without prescription would reduce the workload of GPs.